Trial Profile
Clinical Trials Insight: 700023696
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 11 Jun 2007
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb; Medarex
- 11 Jun 2007 New trial record.